Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Pan-cancer analysis and experimental validation of DTL as a potential diagnosis, prognosis and immunotherapy biomarker

Fig. 5

Results of gene transcription, mRNAs, the enrichment analysis and the clinical correlation analysis of DTL in cancers. A Analysis of the correlation between DTL expression and four kinds of methyltransferases (DNMT1: red, DNMT2: blue, DNMT3A: green, DNMT3B: purple). B Analysis the drugs, targets and miRNAs from miRBase databases may interact with DTL (drugs: purple, targets: blue, miRNAs: yellow). C Results of GSEA analysis containing the enrichment analysis of KEGG and hallmark pathways [33,34,35]. D Analysis the differentially expressed genes between the high and low DTL expressed groups in LIHC and the GO enrichment analysis of them were demonstrated. E–G This heatmap showed the correlation between the clinical index and the expression of DTL in LIHC, BLCA and STAD, and the boxmap demonstrated details of the pathological stage and original tumor stage (T)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us